pre-S2
Showing 1 - 25 of >10,000
Burn Shock Trial in Cairo (intravenous immunoglobulin)
Completed
- Burn Shock
- intravenous immunoglobulin
-
Cairo, EgyptCairo University
Nov 13, 2022
Obesity, Type 2 Diabetes Trial in Toronto (Dairy-based greek yogurt, Dairy-based cheddar cheese, Plant-based yogurt)
Completed
- Obesity
- Type 2 Diabetes Mellitus
- Dairy-based greek yogurt
- +3 more
-
Toronto, Ontario, CanadaUniversity of Toronto
Oct 12, 2022
Type2 Diabetes, Coronary Artery Disease Trial in Miami (Liraglutide Pen Injector [Victoza], matching liraglutide- pre-filled
Recruiting
- Type2 Diabetes
- Coronary Artery Disease
- Liraglutide Pen Injector [Victoza]
- matching liraglutide-placebo pre-filled pens
-
Miami, FloridaUniversity of Miami
Nov 4, 2022
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following
Active, not recruiting
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
- Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
-
Calgary, Alberta, Canada
- +24 more
Sep 12, 2022
Brain and Renal Regional Oxygenation Using NIRS in Preterm
Completed
- Pre-Term
- Persistent Ductus Arteriosus
- NONIN SenSmart model X-100 near- infrared spectrometer
-
Vilnius, LithuaniaVilnius University Santaros Klinikos Neonatology Center
Jan 3, 2023
Hazardous Alcohol Use Trial in Toronto (Alcohol-focused brief intervention)
Recruiting
- Hazardous Alcohol Use
- Alcohol-focused brief intervention
-
Toronto, Ontario, Canada
- +2 more
Oct 15, 2021
Anesthesia, General Anesthesia, Analgesics, Opioid Trial in Saskatoon (Acetaminophen, Gabapentin, Lidocaine 1% Injectable
Recruiting
- Anesthesia
- +10 more
- Acetaminophen, Gabapentin
- +5 more
-
Saskatoon, Saskatchewan, CanadaRoyal University Hospital
Oct 31, 2022
Surgical Injury Trial in Wuhan (Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato], 0.9% saline)
Not yet recruiting
- Surgical Injury
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- 0.9% saline
-
Wuhan, Hubei, ChinaDepartment of Critical Care Medicine, Union Hospital, Tongji Med
Jul 12, 2022
Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)
Completed
- Pleural Mesothelioma Malignant Advanced
- Pembrolizumab
- +2 more
-
Barcelona, Spain
- +14 more
Aug 23, 2022
Early-stage Breast Cancer, HER2-positive Breast Cancer Trial in Sweden (Docetaxel, Carboplatin, Trastuzumab)
Terminated
- Early-stage Breast Cancer
- HER2-positive Breast Cancer
- Docetaxel
- +8 more
-
Göteborg, Sweden
- +7 more
Sep 22, 2021
Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Radiation Therapy Boost
- +6 more
-
Washington, District of Columbia
- +8 more
Dec 5, 2022
Insulin Sensitivity Trial in Saskatoon (Pulse-based diet, Regular diet)
Completed
- Insulin Sensitivity
- Pulse-based diet
- Regular diet
-
Saskatoon, Saskatchewan, CanadaCollege of Kinesiology, University of Saskatchewan
Oct 19, 2021
Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)
Active, not recruiting
- Breast Neoplasms
- Perjeta Injectable Product
- +13 more
-
Mönchengladbach, GermanyEvangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022
Prostatic Tumors Trial in Toronto (Pre-treatment tumour oxygen measurements)
Active, not recruiting
- Prostatic Neoplasms
- Pre-treatment tumour oxygen measurements
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 4, 2021
Hypertensive Disorder of Pregnancy, Pregnancy Complications, Pre-Eclampsia Trial in Kingston, Montreal (Breastfeeding
Recruiting
- Hypertensive Disorder of Pregnancy
- +4 more
- Breastfeeding self-efficacy (BSE)
-
Kingston, Ontario, Canada
- +1 more
Aug 27, 2021
Peripheral Arterial Disease, Aging Trial in Hershey (Esmolol infusion, Saline infusion, Pre exercise baseline)
Withdrawn
- Peripheral Arterial Disease
- Aging
- Esmolol infusion
- +5 more
-
Hershey, PennsylvaniaMilton S. Hershey Medical Center
Oct 21, 2021
Orthostatic Intolerance, Syncope, Fainting Trial in Calgary (Physical Counter-maneuver, Stress Test, Functional Electrical
Active, not recruiting
- Orthostatic Intolerance
- +3 more
- Physical Counter-maneuver
- +2 more
-
Calgary, Alberta, CanadaUniversity of Calgary
Apr 28, 2021
Glioblastoma Trial in Roma (Blood sample)
Recruiting
- Glioblastoma
- Blood sample
-
Roma, ItalyFondazione Policlinico Universitaro "A. Gemelli" IRCCS
Mar 29, 2023
Mucosal Erosion Trial in Hyderabad (Simethicone 150mg, N Acetyl cysteine 600mg, Simethicone 150mg plus N Acetyl cysteine 600 mg)
Completed
- Mucosal Erosion
- Simethicone 150mg
- +3 more
-
Hyderabad, Telangana, IndiaAsian institute of Gastroenterology
Jul 21, 2023
Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in
Completed
- Stage III Prostate Adenocarcinoma AJCC v7
- +3 more
- Abiraterone Acetate
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 15, 2021
Pain Clinic Staff Harassed by Patients Pre/Post COVID
Recruiting
- Patient Violence
- Behavioral therapy
-
Surrey, British Columbia, CanadaSalem Anaesthesia Pain Clinic
Jul 11, 2023
Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis Trial in Worldwide (BAY3018250, Placebo to BAY3018250)
Not yet recruiting
- Thrombolysis
- Symptomatic Proximal Deep Vein Thrombosis
- BAY3018250
- Placebo to BAY3018250
-
Antwerpen, Belgium
- +43 more
Nov 28, 2023
Role of Pre-operative CPET in Pancreatoduodenectomy
Completed
- Pancreas Cancer
- Periampullary Carcinoma
-
Blackburn, Lancashire, United KingdomEast Lancashire Hospitals NHS Trust
Sep 28, 2023